-

Claritas Rx Named to Inc.’s 2025 Best Workplaces List

Annual List Recognizes the Businesses That Set the Standard for Workplace Success and Awards Excellence in Company Culture

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the leader in technology and analytics to optimize the specialty patient experience, is proud to announce it has been named to Inc.’s 2025 Best Workplaces list, honoring companies that have built exceptional workplaces and vibrant cultures that support their teams and businesses.

“I am thrilled that the thriving environment we cultivated has been named an Inc. Best Workplace. We are humbled and honored to be on the list and will continue to strive to live up to this recognition," said Michael Fitzgibbons, CEO of Claritas Rx.

Share

This year’s list, featured on Inc.com, is the result of comprehensive measurement and evaluation of American companies that have excelled in creating exceptional workplaces and company cultures — whether in-person or remote.

The award process involved a detailed employee survey conducted by Quantum Workplace, covering critical elements such as management effectiveness, perks, professional development, and overall company culture. Each company’s benefits were also audited to determine overall score and ranking. Claritas Rx is among the 514 companies recognized this year.

“When I founded the company 14 years ago, I knew that priority one was always to nurture and maintain a healthy culture. If we could build a team of people inspired by the same values and goals, we could deliver high value to the life sciences industry,” said Michael Fitzgibbons, CEO, Claritas Rx. “I am thrilled that the thriving environment we cultivated has been named an Inc. Best Workplace. We are humbled and honored to be on the list and will continue to strive to live up to this recognition.”

“Inc.’s Best Workplaces program celebrates the exceptional organizations whose workplace cultures address their employees’ welfare and needs in meaningful ways,” says Bonny Ghosh, editorial director at Inc. “As companies expand and adapt to changing economic forces, maintaining such a culture is no small feat. Yet these honorees have not only achieved it—they continue to elevate the employee experience through thoughtful benefits, engagement, and a deep commitment to their teams.”

To view the full list of winners, visit Inc.com.

About Inc.

Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit www.inc.com.

About Claritas Rx

Based in South San Francisco, CA, Claritas Rx is a technology company focused on managing real world data focused on specialty biopharmaceutical distribution channels in oncology and rare/orphan diseases. Since 2011, the company has illuminated brand performance and the patient journey for dozens of therapies. Claritas Rx creates actionable business intelligence that helps manufacturers more effectively go to market and enhance the patient experience. For more information, visit www.claritasrx.com.

Contacts

Media Contact: Elizabeth Marshall, EMarshall@ClaritasRx.com

Claritas Rx


Release Versions

Contacts

Media Contact: Elizabeth Marshall, EMarshall@ClaritasRx.com

More News From Claritas Rx

Claritas Rx Appoints Biopharma Commercial Leader Jonathan Witt to Board of Directors

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the patient journey experts, today announced the appointment of Jonathan Witt to its Board of Directors. Mr. Witt is an accomplished senior executive with more than 25 years of experience in U.S. and global biopharmaceutical roles. He has a proven record of evaluating market opportunities across diverse therapeutic areas, setting development, commercialization, and corporate strategy, building and scaling enterprise capabilities, and tr...

Relay Network and Claritas Rx Announce Strategic Partnership to Advance Patient Engagement for Specialty and Rare Disease Programs

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the patient journey experts, and Relay Network, a leader in HIPAA-Compliant, mobile-first patient engagement, today announced a strategic partnership to help life sciences companies close critical gaps in patient access, support, and adherence. The collaboration combines Claritas Rx’s specialty pharmacy, hub, and program-level data with Relay Network’s interactive, feed-based communication channel to deliver personalized, 1:1 mobile exp...

Everest Group Finds Patients in Rare and Specialty Markets Are Getting More Touches and Less Help

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the patient journey experts, today announced the release of a new Everest Group white paper: From Fragmented to Orchestrated: Omnichannel Engagement in Patient Services. The white paper addresses a persistent challenge in life sciences: despite significant investment in omnichannel patient engagement, most patient support programs still deliver fragmented, inconsistent experiences. Patients receive repeated outreach, conflicting guidance...
Back to Newsroom